ananthvikas

Demystifying Anemia - An effort in spreading awareness and working towards the goal of “Anemia Mukt Bharat” @MoHFW_INDIA @mybmcwardKW @Blues_Blue34 @ananthvikas @nihardesai89 @Neuberg_Diag

I'm working on a teaching presentation on Hodgkin's lymphoma. Picture below contains HRS-like cells from 9 different cases. Which ones are classical Hodgkin's lymphoma and which ones are something else? #hemepath #pathtwitter #pathology

Equity in cancer diagnosis is not just a technical challenge but a moral imperative. Cancer is not merely a disease of the affluent; it is a leading cause of death worldwide. bmjoncology.bmj.com/content/4/1/e0…

A thought-provoking editorial with a very clear message - A must-read if you are involved in cancer diagnostics or care in any way.

Some lovely group photos from the fantastic B MRD guideines meeting. Great initiative by @CytometryIndia team and big thanks to @LabOrfao for his whole hearted support for this meeting @PrashantTembha1

National B MRD consensus guidelines by @CytometryIndia group led by @PrashantTembha1 and TCS team - the journey begins !

Full house for an important session on #flowcytometer setup by @drkunalsehgal . @CytometryIndia

Starting day 1 of the landmark B-ALL consensus meeting with right earnest at ⁦@ACTREC_TMC⁩. ⁦@CytometryIndia⁩

@drkunalsehgal @PrashantTembha1 @Gaurav_C42 And the magic continues.. @LabOrfao

@drkunalsehgal @PrashantTembha1 @Gaurav_C42

The BMRD #flowcytometry workshop at ⁦@ACTREC_TMC⁩ is off to a great start with amazing talks from ⁦@P_G_Subramanian⁩ , ⁦@LabOrfao⁩ and ⁦@RajpalSweta⁩ . Lot of insightful discussions and revelations, in a packed hall! ⁦@CytometryIndia⁩ ⁦

Did you know… Not all CD38 directed targeted therapy has the same impact on flow cytometry studies. To learn more, see this recent report in the @BrJHaem brought to you by @AfshinShameli . doi.org/10.1111/bjh.20…

Excellent article and image explaining the impact of Anti CD38 monoclonal antibodies on flow Cytometry testing. Knowing the clone you use in practice and clinical scenario becomes even more vital @CytometryIndia @PrashantTembha1 @ananthvikas

"Global Oncology Inequities: The Cost of ‘Not Otherwise Specified’ in WHO Tumor Classifications 🧵" A tweetorial

@Nivedit76302746 What a treat to listen to @Pradeepv951 !

#Kapcon2025.. you have given pathology a gem

What a session …. Dr Pradeep .. so so proud

Ever wondered why CD10, a go-to marker in lymphoma, also shows up in tissues like the kidney, skin, or uterus? 🤔 To understand this, we need to explore what CD10 really is at the molecular level. A short thread on CD10, its biology, and what its positivity means beyond lymphomas. 🧵👇 #pathx #molpath #hemepath

17TH TCS ANNUAL CONFERENCE & WORKSHOPS-2025 REGISTER HERE tcs.res.in/event2025 #flowcytometry, #ICCSSummit2025, #CSIR, #CSIR_IND, #university,#iisc #AIIMS, #IIT ,⁦@CytometryIndia ⁩ ⁦@PrashantTembha1, @DrAnilHandoo, @drkunalsehgal, @ananthvikas ⁩ ⁦

Join us for an Exciting meeting on "Consensus Recommendations and Workshops: Technical & Analytic Aspects of flow Cytometric B-ALL MRD" - An initiative by @CytometryIndia @ICCS_Education